Literature DB >> 23521129

Evaluation of K(HYNIC)(2) as a bifunctional chelator for (99m)Tc-labeling of small biomolecules.

Shundong Ji1, Yang Zhou, Guoqiang Shao, Shuang Liu.   

Abstract

This study sought to evaluate K(HYNIC)(2) (K = lysine and HYNIC = 6-hydrazinonicotinyl) as a bifunctional chelator for (99m)Tc-labeling of biomolecule. In this study, four K(HYNIC)(2)-conjugated cyclic RGD peptides, K(HYNIC)(2)-RGD(2) (RGD(2) = E[c(RGDfK)](2)), K(HYNIC)(2)-3G-RGD(2) (3G-RGD(2) = Gly-Gly-Gly-E[Gly-Gly-Gly-c(RGDfK)](2)), K(HYNIC)(2)-2P-RGD(2) (2P-RGD(2) = E[PEG4-c(RGDfK)](2), and PEG(4) = 15-amino-4,7,10,13-tetraoxapentadecanoic acid), and K(HYNIC)(2)-3P-RGD(2) (3P-RGD(2) = PEG4-E[PEG4-c(RGDfK)]2) were prepared, and evaluated for their integrin αvβ3 binding affinity. IC(50) values were determined to be 47 ± 2, 35 ± 2, 37 ± 2, 85 ± 2, and 422 ± 15 nM for K(HYNIC)(2)-2P-RGD(2), K(HYNIC)(2)-3P-RGD(2), K(HYNIC)(2)-3G-RGD(2), K(HYNIC)(2)-RGD(2), and c(RGDyK), respectively, against (125)I-echistatin bound to U87MG cells. Macrocyclic complexes [(99m)Tc(K(HYNIC)(2)-RGD(2))(tricine)] (1), [(99m)Tc(K(HYNIC)(2)-3G-RGD(2))(tricine)] (2), [(99m)Tc(K(HYNIC)(2)-2P-RGD(2))(tricine)] (3), and [(99m)Tc(K(HYNIC)(2)-3P-RGD(2))(tricine)] (4) were prepared, and evaluated in athymic nude mice bearing U87MG glioma xenografts for their tumor targeting capability and biodistribution. It was found that 1-4 all had high solution stability and more than two isomers, as evidenced by the presence of multiple radiometric peaks in their radio-HPLC chromatograms. The tumor uptake of 1-4 was 3.78 ± 0.81, 7.46 ± 1.68, 9.74 ± 1.65, and 8.59 ± 1.52%ID/g, respectively, which was completely consistent with trend of integrin α(v)β(3) binding affinity for cyclic RGD peptides. Replacing [(99m)Tc(HYNIC)(tricine)(TPPTS)] (TPPTS = trisodium triphenylphosphine-3,3',3"-trisulfonate) with [(99m)Tc(K(HYNIC)(2))(tricine)] had little impact on radiotracer tumor uptake; but it had significant effect on the uptake of radiotracer in kidneys, lungs, and spleen. The tumor was clearly visualized by SPECT/CT with excellent contrast in a glioma-bearing mouse administered with 4. K(HYNIC)(2) would be particularly useful for (99m)Tc-labeling of small biomolecules with one or more disulfide linkages.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23521129      PMCID: PMC3667555          DOI: 10.1021/bc3006896

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  42 in total

1.  Technetium-99m somatostatin analogues: effect of labelling methods and peptide sequence.

Authors:  C Decristoforo; S J Mather
Journal:  Eur J Nucl Med       Date:  1999-08

2.  99mTc-Labeled Small Peptides as Diagnostic Radiopharmaceuticals.

Authors:  S Liu; D S Edwards
Journal:  Chem Rev       Date:  1999-09-08       Impact factor: 60.622

3.  A novel method to label liposomes with 99mTc by the hydrazino nicotinyl derivative.

Authors:  P Laverman; E T Dams; W J Oyen; G Storm; E B Koenders; R Prevost; J W van der Meer; F H Corstens; O C Boerman
Journal:  J Nucl Med       Date:  1999-01       Impact factor: 10.057

4.  Evaluation of 99mTc-labeled cyclic RGD dimers: impact of cyclic RGD peptides and 99mTc chelates on biological properties.

Authors:  Yang Zhou; Young-Seung Kim; Xin Lu; Shuang Liu
Journal:  Bioconjug Chem       Date:  2012-03-06       Impact factor: 4.774

5.  Technetium-99m-labeled hydrazino nicotinamide derivatized chemotactic peptide analogs for imaging focal sites of bacterial infection.

Authors:  J W Babich; H Solomon; M C Pike; D Kroon; W Graham; M J Abrams; R G Tompkins; R H Rubin; A J Fischman
Journal:  J Nucl Med       Date:  1993-11       Impact factor: 10.057

6.  99mTc-EDDA/HYNIC-TOC: a new 99mTc-labelled radiopharmaceutical for imaging somatostatin receptor-positive tumours; first clinical results and intra-patient comparison with 111In-labelled octreotide derivatives.

Authors:  C Decristoforo; S J Mather; W Cholewinski; E Donnemiller; G Riccabona; R Moncayo
Journal:  Eur J Nucl Med       Date:  2000-09

7.  Coligand effects on the solution stability, biodistribution and metabolism of the (99m)Tc-labeled cyclic RGDfK tetramer.

Authors:  Shuang Liu; Young-Seung Kim; Wen-Yuan Hsieh; Subramanya Gupta Sreerama
Journal:  Nucl Med Biol       Date:  2007-11-19       Impact factor: 2.408

8.  Monitoring glioma growth and tumor necrosis with the U-SPECT-II/CT scanner by targeting integrin αvβ3.

Authors:  Guoqiang Shao; Yang Zhou; Feng Wang; Shuang Liu
Journal:  Mol Imaging       Date:  2013 Jan-Feb       Impact factor: 4.488

9.  99mTcO(MAG2-3G3-dimer): a new integrin alpha(v)beta(3)-targeted SPECT radiotracer with high tumor uptake and favorable pharmacokinetics.

Authors:  Jiyun Shi; Lijun Wang; Young-Seung Kim; Shizhen Zhai; Bing Jia; Fan Wang; Shuang Liu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-05-30       Impact factor: 9.236

10.  Evaluation of a (99m)Tc-labeled cyclic RGD tetramer for noninvasive imaging integrin alpha(v)beta3-positive breast cancer.

Authors:  Shuang Liu; Wen-Yuan Hsieh; Young Jiang; Young-Seung Kim; Subramanya G Sreerama; Xiaoyuan Chen; Bing Jia; Fan Wang
Journal:  Bioconjug Chem       Date:  2007-03-07       Impact factor: 4.774

View more
  6 in total

1.  Comparison of biological properties of 99mTc-labeled cyclic RGD Peptide trimer and dimer useful as SPECT radiotracers for tumor imaging.

Authors:  Zuo-Quan Zhao; Yong Yang; Wei Fang; Shuang Liu
Journal:  Nucl Med Biol       Date:  2016-02-27       Impact factor: 2.408

Review 2.  Radiolabeled Cyclic RGD Peptide Bioconjugates as Radiotracers Targeting Multiple Integrins.

Authors:  Shuang Liu
Journal:  Bioconjug Chem       Date:  2015-08-03       Impact factor: 4.774

3.  Investigation of SP94 Peptide as a Specific Probe for Hepatocellular Carcinoma Imaging and Therapy.

Authors:  Yanli Li; Yan Hu; Jie Xiao; Guobing Liu; Xiao Li; Yanzhao Zhao; Hui Tan; Hongcheng Shi; Dengfeng Cheng
Journal:  Sci Rep       Date:  2016-09-21       Impact factor: 4.379

Review 4.  Radiolabeled cyclic RGD peptides as radiotracers for tumor imaging.

Authors:  Jiyun Shi; Fan Wang; Shuang Liu
Journal:  Biophys Rep       Date:  2016-04-12

5.  Rhenium and Technetium-oxo Complexes with Thioamide Derivatives of Pyridylhydrazine Bifunctional Chelators Conjugated to the Tumour Targeting Peptides Octreotate and Cyclic-RGDfK.

Authors:  Andrea J North; John A Karas; Michelle T Ma; Philip J Blower; Uwe Ackermann; Jonathan M White; Paul S Donnelly
Journal:  Inorg Chem       Date:  2017-08-02       Impact factor: 5.165

6.  Novel Arginine-containing Macrocyclic MMP Inhibitors: Synthesis, 99mTc-labeling, and Evaluation.

Authors:  Yunpeng Ye; Jakub Toczek; Kiran Gona; Hye-Yeong Kim; Jinah Han; Mahmoud Razavian; Reza Golestani; Jiasheng Zhang; Terence L Wu; Mousumi Ghosh; Jae-Joon Jung; Mehran M Sadeghi
Journal:  Sci Rep       Date:  2018-08-03       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.